Floatz logo

Umbilical Cord Blood Cell Infusion

Hodgkin's Disease

Mesoblast, Ltd.Cell therapyPhase 3Dormant
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
47/ 100
Competitive Position
95/ 100

Competitive context

150 Active assets in the Hodgkin's Disease cohort.

Asset / SponsorPhaseRating
CYCLOSPORIN A
City of Hope Medical Center
Phase 3BBB
FILGRASTIM
Fred Hutchinson Cancer Center
Phase 3BBB
Cytosin-Arabinosid
Therapeutic Advances in Childhood Leukemia Consortium
Phase 3BBB
CARMUSTINE
VIVUS LLC
Phase 2BBB
Carboplatin
St. Petersburg State Pavlov Medical University
Phase 2BBB

View all 50 →

Same molecule, other indications

Umbilical Cord Blood Cell Infusion is also rated in:

acute myeloid leukemiaDormant
B
Indicative ·
61 / 100
View asset →
non-Hodgkin lymphomaDormant
B
Indicative ·
56 / 100
View asset →
acute lymphoblastic leukemiaDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →